G. Ozen Et Al. , "Downregulation of PGI(2) pathway in Pulmonary Hypertension Group-III patients," PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS , vol.160, 2020
Ozen, G. Et Al. 2020. Downregulation of PGI(2) pathway in Pulmonary Hypertension Group-III patients. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS , vol.160 .
Ozen, G., Amgoud, Y., Abdelazeem, H., Mani, S., Benyahia, C., Bouhadoun, A., ... Tran-Dinh, A.(2020). Downregulation of PGI(2) pathway in Pulmonary Hypertension Group-III patients. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS , vol.160.
Ozen, Gülsev Et Al. "Downregulation of PGI(2) pathway in Pulmonary Hypertension Group-III patients," PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS , vol.160, 2020
Ozen, Gülsev Ö. Et Al. "Downregulation of PGI(2) pathway in Pulmonary Hypertension Group-III patients." PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS , vol.160, 2020
Ozen, G. Et Al. (2020) . "Downregulation of PGI(2) pathway in Pulmonary Hypertension Group-III patients." PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS , vol.160.
@article{article, author={Gülsev ÖZEN YORGANCIGİL Et Al. }, title={Downregulation of PGI(2) pathway in Pulmonary Hypertension Group-III patients}, journal={PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS}, year=2020}